Youn Byung-S, Min Sung Shik, Park Kyong Soo, Lee Hyeon W, Yu Rina, Kwon Byoung S
KOMED Institute for Life Science, Korea University, Seoul, Korea.
Drug News Perspect. 2004 Jun;17(5):293-8. doi: 10.1358/dnp.2004.17.5.829032.
It is becoming clear that adipose tissue is not merely a storage for excess energy but that it secretes a number of biologically active soluble factors collectively termed adipocytokines that control glucose and fatty acid metabolism. Of these adipocytokines, adiponectin and resistin have been the objects of intensive research, as they are implicated in obesity and diabetes-related diseases. In this review, we summarize recent advances in understanding the roles of adiponectin and resistin in the causation of metabolic diseases and consider the prospects for treating metabolic disorders by targeting these two adipocytokines.
越来越明显的是,脂肪组织不仅仅是多余能量的储存库,它还分泌多种具有生物活性的可溶性因子,这些因子统称为脂肪细胞因子,可控制葡萄糖和脂肪酸代谢。在这些脂肪细胞因子中,脂联素和抵抗素一直是深入研究的对象,因为它们与肥胖症和糖尿病相关疾病有关。在这篇综述中,我们总结了在理解脂联素和抵抗素在代谢疾病病因中的作用方面的最新进展,并考虑了通过靶向这两种脂肪细胞因子来治疗代谢紊乱的前景。